Phase 3 Ocular Myasthenia Gravis Clinical Trials
2 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Ocular Myasthenia Gravis
UCB Biopharma SRL120 enrolled2 locationsNCT07463521
Recruiting
Phase 3
Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial.
Ocular Myasthenia Gravis
Fondation Ophtalmologique Adolphe de Rothschild128 enrolled11 locationsNCT06342544